GR
Grace Therapeutics, Inc. (GRCE)
NASDAQ·Healthcare·Biotechnology
$2.12
-1.85%
Mkt Cap $55.53M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | — | — | — | -$0.09 | -$0.14 | -55.56% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.12 | -$0.15 | -25.00% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.22 | -$0.21 | +4.55% | — | — |
| Q2 2025 Jun 23, 2025 | — | — | — | -$0.20 | -$0.21 | -5.00% | — | — |
| Q1 2025 Feb 13, 2025 | — | — | — | -$0.24 | -$0.26 | -8.33% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.33 | -$0.33 | +0.00% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.28 | -$0.24 | +14.29% | — | — |
| Q2 2024 Jun 21, 2024 | — | — | — | -$0.35 | -$0.18 | +48.57% | — | — |
| Q1 2024 Feb 12, 2024 | — | — | — | -$0.23 | -$0.24 | -4.44% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.26 | -$0.32 | -23.05% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.28 | -$0.41 | -45.86% | — | — |
| Q2 2023 Jun 23, 2023 | — | — | — | -$0.84 | -$2.89 | -244.16% | — | — |
| Q1 2023 Feb 14, 2023 | — | — | — | -$0.74 | -$0.39 | +47.32% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | — | -$0.48 | — | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | — | -$0.48 | — | — | — |
| Q2 2022 Jun 21, 2022 | — | — | — | — | -$0.46 | — | — | — |
| Q1 2022 Feb 14, 2022 | — | — | — | — | -$0.40 | — | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | — | $0.14 | — | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | — | -$0.58 | — | — | — |
| Q2 2021 Jun 22, 2021 | — | $91.50K | — | — | -$1.32 | — | — | — |